Premium
First reported case of interferon‐alpha‐induced sarcoidosis in an A sian patient with malignant melanoma
Author(s) -
Jeon Eun Kyoung,
Hong Jihyoung,
Hong Sook Hee,
Kang Ji Young,
Park Gyeongsin,
Ahn Myeong Im,
Lee Jun Young,
Kang Jinhyoung
Publication year - 2016
Publication title -
asia‐pacific journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.73
H-Index - 29
eISSN - 1743-7563
pISSN - 1743-7555
DOI - 10.1111/ajco.12204
Subject(s) - sarcoidosis , melanoma , medicine , alpha interferon , malignancy , dermatology , interferon alfa , interferon , cancer , cancer research , pathology , immunology
Anticancer agents can induce sarcoidosis. Interferon‐alpha, which is used for the treatment of malignant melanoma and renal cell cancer, is one causative agent of sarcoidosis. However, there are few reports of interferon‐alpha‐induced sarcoidosis in patients with malignant melanoma. Clinically, it is important to consider the possibility of sarcoidosis in such patients because it could be easily regarded as a metastatic lesion due to underlying malignancy and given unnecessary treatment. Here, we report on the first case of interferon‐alpha‐induced sarcoidosis in an Asian melanoma patient.